Compare TK & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TK | AORT |
|---|---|---|
| Founded | 1973 | 1984 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 925.8M | 1.1B |
| IPO Year | 1995 | 1996 |
| Metric | TK | AORT |
|---|---|---|
| Price | $11.27 | $27.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $49.40 |
| AVG Volume (30 Days) | 513.5K | ★ 550.4K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | ★ 15.21% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | N/A | $11.20 |
| P/E Ratio | ★ $13.43 | $886.00 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $7.34 | $19.16 |
| 52 Week High | $14.38 | $48.25 |
| Indicator | TK | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 50.43 | 57.36 |
| Support Level | $11.25 | $19.49 |
| Resistance Level | $12.50 | $37.65 |
| Average True Range (ATR) | 0.41 | 0.95 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 49.58 | 54.28 |
Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.